PANews reported on February 20th that, according to The Block, BGD Labs, a core technology contributor to Aave, announced it will not renew its service contractPANews reported on February 20th that, according to The Block, BGD Labs, a core technology contributor to Aave, announced it will not renew its service contract

BGD Labs ceased providing technical contributions to Aave starting in April.

2026/02/20 21:29
1 min read

PANews reported on February 20th that, according to The Block, BGD Labs, a core technology contributor to Aave, announced it will not renew its service contract with Aave DAO after it expires on April 1st, ending nearly four years of cooperation. BGD stated it will continue to fulfill its responsibilities to date, including Aave v3, Umbrella, on-chain scaling, asset listing, and security maintenance, and plans to release documentation and maintenance guidelines to facilitate other teams taking over. BGD pointed out that Aave Labs is in a more central position in the development of Aave v4 and the protocol reorganization, controlling brand, communication channels, and voting influence, leading to decentralized governance deviations and "asymmetric organizational structure" issues. BGD also proposed providing optional security advisory services for two months from April to June, worth $200,000, subject to governance approval.

Market Opportunity
AaveToken Logo
AaveToken Price(AAVE)
$117.49
$117.49$117.49
-0.08%
USD
AaveToken (AAVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.